Methods of treating schizophrenia

a treatment method and schizophrenia technology, applied in the field of schizophrenia treatment, can solve the problems of abnormal levels of various neurochemicals and/or abnormal responsiveness to neurochemicals, adverse effects on higher level executive functions, and many dopamine antagonist antipsychotic drugs are not as effective at controlling “negative” symptoms, so as to improve cognitive function and improve cognitive deficits
US20060292128A1Inactive Publication Date: 2006-12-28TITAN PHARMA
7 Cites 4 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
TITAN PHARMA
Publication Date
2006-12-28
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention provides methods for the treatment of abnormal psychiatric states, particularly the negative symptoms of schizophrenia and extrapyramidal side effects (EPS) of antipsychotic drugs. The inventive methods relate to the administration of therapeutic cells (which produce dopamine or dopamine precursors) adhered to support matrices to subjects suffering from the negative symptoms of schizophrenia and / or EPS. The therapeutic cells may be coadministered with cells which protect the therapeutic cells from immune rejection and / or cells which produce neurotrophic factors which improve the viability of the therapeutic cells.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application is a divisional of U.S. application Ser. No. 09 / 289,576, filed Apr. 9, 1999, which is herein incorporated by reference in its entirety.TECHNICAL FIELD

[0002] The invention relates generally to the treatment of psychiatric disorders, and particularly to methods of treating negative symptoms of schizophrenia and / or certain extrapyramidal side effects (EPS) of antipsychotics by administering an effective number of cells, adhered to a support matrix, which are capable of producing dopamine or a dopamine precursor to a subject suffering from schizophrenia. BACKGROUND

[0003] Disorders of the nervous system comprise a wide variety of conditions, and can generally be separated into “neurological disorders” and “psychiatric disorders”. Neurological disorders can be characterized as the product of the death of nervous system cells. Examples of neurological disorders include Parkinson's Disease, which involves the death of dopamin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More